Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspective

被引：0
|
作者：
Michela Nosè
Maria Angela Mazzi
Eleonora Esposito
Marco Bianchini
Paola Petrosemolo
Giovanni Ostuzzi
Michele Tansella
Corrado Barbui
机构：
[1] University of Verona,Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology
来源：
Social Psychiatry and Psychiatric Epidemiology | 2012年 / 47卷
关键词：
Antipsychotic; Tolerability; Side effect; Drug epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：157 / 164
页数：7
相关论文
共 50 条
  • [31] Potential Adverse Effects of Discontinuing Psychotropic Drugs Part 3: Antipsychotic, Dopaminergic, and Mood-Stabilizing Drugs
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2010, 48 (08) : 12 - 15
  • [32] Antipsychotic drugs & their side effects
    Jacob, Rajesh
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2009, 129 (02) : 208 - 209
  • [33] Extrapyramidal effects of antipsychotic drugs
    Kulisevsky, J
    Otermin, P
    NEUROLOGIA, 2003, 18 (05): : 262 - 268
  • [34] MAJOR DIFFERENCES IN ADVERSE EVENTS WITH ANTIPSYCHOTIC DRUGS BETWEEN PEDIATRIC AND ADULT PATIENTS.
    Liu, X.
    Schuette, P.
    Green, D.
    La, J.
    Burnham, J.
    van den Anker, J.
    Huang, S.
    Burckart, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S42 - S43
  • [35] Antipsychotic drugs - information and choice: a patient survey
    Olofinjana, Banke
    Taylor, David
    PSYCHIATRIC BULLETIN, 2005, 29 (10): : 369 - 371
  • [36] Aripiprazole versus typical antipsychotic drugs for schizophrenia
    Bhattacharjee, Jayanti
    El-Sayeh, Hany George G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [37] Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
    Saha, Kumar B.
    Bo, Li
    Zhao, Sai
    Xia, Jun
    Sampson, Stephanie
    Zaman, Rashid U.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [38] ADVERSE-EFFECTS OF ANTIPSYCHOTIC AGENTS
    SIMPSON, GM
    PI, EH
    SRAMEK, JJ
    DRUGS, 1981, 21 (02) : 138 - 151
  • [39] Pharmacogenomics of antipsychotic adverse effects: Focus on antipsychotic induced parkinsonism
    Lerer, B.
    Greenbaum, L.
    Strous, R.
    Rigbi, A.
    Lancet, D.
    Kanyas, K.
    Ben-Asher, E.
    Smith, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 33 - 33
  • [40] Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose–insulin homeostasis and lipid metabolism
    K. I. Melkersson
    M.-L. Dahl
    A.-L. Hulting
    Psychopharmacology, 2004, 175 : 1 - 6
12345